Rush offers stem cell transplants, bone marrow transplants and other advanced treatments for leukemia, lymphoma, multiple myeloma and other blood diseases.
A National Leader in Bone Marrow Transplant
Rush bone marrow transplant patients have excellent outcomes: The Center for International Blood and Marrow Transplant Research registry confirms our 100% patient survival rate for the first 180 days after transplant.
The Rush Approach to Bone Marrow Transplant (BMT)
Bone marrow or stem cell transplant might be a lifesaving option if you have a blood cancer like leukemia or lymphoma that hasn't responded to standard treatment. It is also an option for a bone marrow disease such as amyloidosis or aplastic anemia, or another blood condition like sickle cell disease.
A bone marrow transplant uses stem cells collected from your own bone marrow (autologous transplant) or a donor's bone marrow (allogeneic transplant). A stem cell transplant uses cells from donor blood or your own blood.
Rush also offers cord blood transplants if you need a donor transplant but don’t have a match. To use donor cells, you and your donor have to be a close match — but cord blood doesn't require as close a match. Our use of cord blood means that no patient goes without a donor.
Rush University Medical Center was one of the first centers in Chicago to offer chimeric antigen receptor T-cell therapy (CAR T-cell therapy) for patients with certain types of leukemia and lymphoma. CAR T-cell therapy modifies your own T-cells to recognize and destroy cancer cells, enabling you to respond to chemotherapy and qualify for a bone marrow transplant.
Rush Excellence in Bone Marrow Transplant
- National accreditation: Rush's BMT team provides the highest level of care in the safest way possible. We're fully accredited by the Foundation for the Accreditation of Cellular Therapy (FACT) in recognition of our transplant program's quality and safety.
- Fast-track clinic: Our fast-track BMT clinic is open 365 days a year. This clinic helps you transition from inpatient to outpatient care by providing post-transplant care, chemotherapy and CAR T-cell therapy infusions. Housed in the inpatient BMT unit at Rush University Medical Center, the clinic is here for you if you experience any issues or side effects. This may allow you to have a shorter inpatient stay, and avoid the emergency room later.
- Expert, collaborative team: Our team includes experienced transplant physicians, fellowship-trained BMT specialists and advanced practice providers who work only with BMT patients, providing you with focused, personal attention and ensuring seamless care.
- Quality of life: Making sure you have good quality of life as a transplant patient is our top priority. We don't focus only on your physical treatment — we also focus on the mental, emotional and social aspects.
- Research that's redefining the field: Our BMT specialists conduct clinical and translational research, including research on transplantation immunology that helps us continue to improve treatment options and long-term outcomes.